<?xml version="1.0" encoding="UTF-8"?>
<p>The model has wide application. It has been used regionally to map critical care drug requirements to available stock in both Trusts and wholesalers/suppliers. This has enabled the identification of treatment capacity for these medicines regionally, both currently and for projected surges, expressed as both the number of critical care patient stock days and total number of patients treated for the duration of their ICU stay. An example of how calculated projected drug requirement (expressed as singles) can be mapped to available stock from Trusts and wholesalers is shown in 
 <xref rid="T3" ref-type="table">table 3</xref>.
</p>
